Citation Impact
Citing Papers
Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
1992
Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase
2007 StandoutNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Albuminuria in Mice after Injection of Antibodies against Aminopeptidase A
2001 StandoutNobel
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.
1996
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Captopril
1988
Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II
1990
CIRCULATING ANGIOTENSIN II LEVELS UNDER REPEATED ADMINISTRATION OF LISINOPRIL IN NORMAL SUBJECTS
1992
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
Chymase-dependent angiotensin II forming system in humans
1996
The pathogenesis of cardiac fibrosis
2013 Standout
Measurement of immunoreactive angiotensin peptides in rat tissues: Some pitfalls in angiotensin II analysis
1988
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Evidence of a Partial Escape of Renin‐Angiotensin‐Aldosterone Blockade in Patients with Acute Myocardial Infarction Treated with Ace Inhibitors
1993
On the origin of the catalytic power of carboxypeptidase A and other metalloenzymes
2009 StandoutNobel
Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase
1999
Endothelin A Receptor Antagonism and Angiotensin-Converting Enzyme Inhibition Are Synergistic via an Endothelin B Receptor–Mediated and Nitric Oxide–Dependent Mechanism
2004
Renal Tissue Angiotensins During Converting Enzyme Inhibition in the Spontaneously Hypertensive Rat
1997
Radioimmunoassay for immunoreactive [des-Leu10]-angiotensin I
1989
Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice
2004 StandoutNobel
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Mice with Cardiac-Restricted Angiotensin-Converting Enzyme (ACE) Have Atrial Enlargement, Cardiac Arrhythmia, and Sudden Death
2004 StandoutNobel
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.
1997 StandoutNobel
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Is there a local renin–angiotensin system in the heart?
1999
Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.
1993
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
2000 Standout
A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study
2001 Standout
EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN
1989 Standout
Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
1996
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Effect of prolactin on the active Na transport across Rana catesbeiana skin during metamorphosis
1989
Blood Pressure, Cardiac, and Renal Responses to Salt and Deoxycorticosterone Acetate in Mice
2002
Long-Term Complications of Diabetes Mellitus
1993 Standout
Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II
1999
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
1991 StandoutNature
Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure
1989
Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure
2003
Reassessment of plasma angiotensins measurement: Effects of protease inhibitors and sample handling procedures
1991
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells
1999 StandoutNobel
Hemodynamic, Hormonal, and Renal Effects of Short-Term Adrenomedullin Infusion in Healthy Volunteers1
2000
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
2006 Standout
Effect of Bradykinin-Receptor Blockade on the Response to Angiotensin-Converting–Enzyme Inhibitor in Normotensive and Hypertensive Subjects
1998
Biomarkers in Heart Failure
2008 Standout
Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
2000 StandoutNobel
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
1988 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.
1989
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
2000 Standout
Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis
1987
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Angiotensin levels in the eye.
1994
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.
1993
Blood Pressure–Independent Cardiac Hypertrophy Induced by Locally Activated Renin-Angiotensin System
1998
Increased Cardiac Angiotensin II Levels Induce Right and Left Ventricular Hypertrophy in Normotensive Mice
2000
Tubuloglomerular feedback in ACE-deficient mice
1999 StandoutNobel
Angiotensin-Converting Enzyme Gene Polymorphism Has No Influence on the Circulating Renin-Angiotensin-Aldosterone System or Blood Pressure in Normotensive Subjects
1995
Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart
1997
Augmented Short- and Long-Term Hemodynamic and Hormonal Effects of an Angiotensin Receptor Blocker Added to Angiotensin Converting Enzyme Inhibitor Therapy in Patients With Heart Failure
1999
Hydrolysis by Cathepsin B of Fluorescent Peptides Derived From Human Prorenin
2000 StandoutNobel
Sensitivity of Blood Pressure and Renin Activation During Sodium Restriction
1997
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Angiotensin-Converting Enzyme Inhibition Improves Vascular Function in Rheumatoid Arthritis
2008
Determinants of angiotensin II generation during converting enzyme inhibition.
1990
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Angiotensin II Sensitivity Is Associated With the Angiotensin II Type 1 Receptor A 1166 C Polymorphism in Essential Hypertensives on a High Sodium Diet
2000
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
Targeting G βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
1999 StandoutNobel
Evidence for the Existence of a Functional Cardiac Renin-Angiotensin System in Humans
1996
Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo
2007 StandoutNobel
Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension.
1990
Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.
1991
Mice Lacking Endothelial ACE
2003 StandoutNobel
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.
1986
Role of Angiotensin Converting Enzyme Inhibitors in Essential and Renal Hypertension
1984
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
2000 Standout
Regulation of protease nexin-1 expression in cultured Schwann cells is mediated by angiotensin II receptors
1995
Angiotensin-Converting Enzyme Inhibitors
1998
In Vitro and In Vivo Inhibition of the 2 Active Sites of ACE by Omapatrilat, a Vasopeptidase Inhibitor
2000
Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis.
1994
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
The Design and Properties of N‐Carboxyalkyldipeptide Inhibitors of Angiotensin‐Converting Enzyme
1985
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.
1990
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries.
1993
Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart Failure
1986
Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats.
1992
Opposing Actions of Angiotensin II on Microvascular Growth and Arterial Blood Pressure
1996
Mice Lacking Endothelial Angiotensin-Converting Enzyme Have a Normal Blood Pressure
2002 StandoutNobel
Lipopolysaccharide Endotoxins
2002 Standout
Similarities of genetic (spontaneous) hypertension. Man and rat.
1981
Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.
1990
Plasma angiotensins and blood pressure during converting enzyme inhibition.
1987
Plasma Renin Activity by LC-MS/MS: Development of a Prototypical Clinical Assay Reveals a Subpopulation of Human Plasma Samples with Substantial Peptidase Activity
2010
Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate Measurement
2009
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Cardiovascular drugs in children: Angiotensin-converting enzyme inhibitors
1988
Aliskiren Reduces Blood Pressure and Suppresses Plasma Renin Activity in Combination With a Thiazide Diuretic, an Angiotensin-Converting Enzyme Inhibitor, or an Angiotensin Receptor Blocker
2006
Plasma renin activity and plasma prorenin assays
1991
Remodeling of the rat right and left ventricles in experimental hypertension.
1990
Recent developments in the design of angiotensin‐converting enzyme inhibitors
1985
Effect of Reduced Angiotensin-Converting Enzyme Gene Expression and Angiotensin-Converting Enzyme Inhibition on Angiotensin and Bradykinin Peptide Levels in Mice
2004
Angiotensin II Type 1 Receptor–Mediated Peroxide Production in Human Macrophages
1999
High Plasma Level ofN-Acetyl-Seryl-Aspartyl-Lysyl-Proline
1997
Works of D. B. Brunner being referenced
Measurement of Converting Enzyme Activity by Antibody-Trapping of Generated Angiotensin II: Comparison With Two Other Methods
1992
In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II
1988
Thyroid hormone-aldosterone interaction on Na+ transport in toad bladder
1979
Lack of angiotensin I accumulation after converting enzyme blockade by enalapril or lisinopril in man
1987
True versus immunoreactive angiotensin II in human plasma.
1985
Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects
2004
Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.
1981
Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I
1981
Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.
1984
Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
1987
A potent converting enzyme inhibitor CGS 13928C. Drug profile in normal volunteers
1984
Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma.
1986
Repeated Administration of the Converting Enzyme Inhibitor Cilazapril to Normal Volunteers
1987
Effect of Captopril on Renal Vascular Tone in Patients with Essential Hypertension
1979
Plasma vasopressin in rats: effect of sodium, angiotensin, and catecholamines
1983
Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
1980
Enalapril maleate and a lysine analogue (MK‐521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.
1982